U.S. Trade Representative Jamieson Greer and chief health department adviser Chris Klomp met with German Ambassador Jens Hanefeld to press Germany to raise its pharmaceutical prices, part of a broader administration effort to lower drug costs for American patients, according to STAT News. Officials raised the possible use of Section 301 tariffs — the same authority used to threaten other trading partners — and the ambassador agreed to consult with Berlin, though no deal was reached.